0001225208-23-010042.txt : 20231107
0001225208-23-010042.hdr.sgml : 20231107
20231107161120
ACCESSION NUMBER: 0001225208-23-010042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231106
FILED AS OF DATE: 20231107
DATE AS OF CHANGE: 20231107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahoney Michael F
CENTRAL INDEX KEY: 0001533022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 231383834
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0508
4
2023-11-06
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001533022
Mahoney Michael F
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
1
Chairman, President & CEO
0
Common Stock
2023-11-06
4
M
0
57681.0000
13.0800
A
1556603.0000
D
Common Stock
2023-11-06
4
M
0
55675.0000
16.3100
A
1612278.0000
D
Common Stock
2023-11-06
4
S
0
113356.0000
52.5070
D
1498922.0000
D
Common Stock
176245.0000
I
By Trust
Stock Option (Right to Buy)
16.3100
2023-11-06
4
M
0
55675.0000
0.0000
D
2025-02-23
Common Stock
55675.0000
167026.0000
D
Stock Option (Right to Buy)
13.0800
2023-11-06
4
M
0
57681.0000
0.0000
D
2024-02-24
Common Stock
57681.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 24, 2023, intended to comply with the prior version of Rule 10b5-1(c).
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.17 to $52.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2023-11-07